METiS AI Drug IPO: $200M Bet on AI-Powered Drug Discovery
METiS Pharmaceuticals Eyes $200M AI Drug IPO Big news in the AI healthcare space: METiS Pharmaceuticals, an AI-driven drug development business based in Hangzhou, is reportedly planning a $200 million AI medicine IPO in Hong Kong before the end of 2025. The company was founded in 2020 and has already raised $300 million, including a […]
METiS AI Drug IPO: $200M Bet on AI-Powered Drug Discovery Read More »